For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Scinai Immunotherapeutics Ltd ADR (NASDAQ: SCNI) closed at $2.55 down -21.54% from its previous closing price of $3.25. In other words, the price has decreased by -$21.54 from its previous closing price. On the day, 0.63 million shares were traded.
Ratios:
For a deeper understanding of Scinai Immunotherapeutics Ltd ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.32. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.17.
Valuation Measures:
As of this moment, Scinai’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.43. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.75 while its Price-to-Book (P/B) ratio in mrq is 0.50.
Stock Price History:
Over the past 52 weeks, SCNI has reached a high of $8.92, while it has fallen to a 52-week low of $1.90. The 50-Day Moving Average of the stock is -1.45%, while the 200-Day Moving Average is calculated to be -22.09%.
Shares Statistics:
A total of 0.85M shares are outstanding, with a floating share count of 0.83M. Insiders hold about 2.25% of the company’s shares, while institutions hold 7.22% stake in the company.
